1. Agid, Y., Ruberg, M., Javoy-Agid, F., Hirsch, E.C., Raissman-Vozari, R., Vyas, S., Faucheux, B., Michel, P., Kastner, A., Blanchard, V., Damier, P., Villares, J. and Zhang, P., Are dopaminergic neurons selectively vulnerable to Parkinson's disease? Adv. Neurol., 60 (1993) 148–164.
2. An updated role for nerve growth factor in neurobehavioural regulation of adult vertebrates;Alleva;Rev. Neurosci.,1993
3. Haloperidol administration in humans lowers plasma NGF levels: evidence that sedation induces opposite effects to arousal;Aloe;Neuropsychobiology,1997
4. Nerve growth factor and autoimmune diseases;Aloe;Autoimmunity,1994
5. The nerve growth factor: purification as a 30 000 molecular-weight protein;Bocchini;Proc. Natl. Acad. Sci. USA,1966